Significant association of RUNX3 T/A polymorphism at intron 3 (rs760805) with the risk of gastric atrophy in Helicobacter pylori seropositive Japanese

Journal of Gastroenterology

Volumn 44, Issue 12, 2009, Pages 1165-1171

  Hishida, Asahi ^a   Matsuo, Keitaro ^b   Goto, Yasuyuki ^a   Mitsuda, Yoko ^a   Naito, Mariko ^a   Wakai, Kenji ^a   Tajima, Kazuo ^b   Hamajima, Nobuyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Gastric atrophy; Gastric cancer; Polymorphism; RUNX3

Indexed keywords

ADENOSINE; ASPARAGINE; ISOLEUCINE; PEPSINOGEN; THYMINE; TRANSCRIPTION FACTOR RUNX3;

ADULT; AGE DETERMINATION; AGED; ARTICLE; ATROPHY; CANCER RISK; CONTROLLED STUDY; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INTRON; JAPANESE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SEX DETERMINATION; STOMACH ATROPHY; STOMACH CANCER; STOMACH CARCINOGENESIS;

ADULT; AGED; CORE BINDING FACTOR ALPHA 3 SUBUNIT; FEMALE; GASTRITIS, ATROPHIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTRONS; JAPAN; MALE; MIDDLE AGED; PEPSINOGEN A; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; STOMACH NEOPLASMS;

EID: 73449119903     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0118-7     Document Type: Article

References (44)

1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents, volume VII. Lyon: IARC Press; 1997.
2. DM Parkin P Pisani J Ferlay 1999 Estimates of the worldwide incidence of 25 major cancers in 1990 Int J Cancer 80 827 841 10.1002/(SICI)1097- 0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P 1:STN:280:DyaK1M7ntlajuw%3D%3D 10074914 (Pubitemid 29108856)
3. Hamilton SR, Aaltonen LA. Pathology and genetics. Tumours of the digestive system. WHO Classification of Tumours. Lyon: IARC Press; 2000.
4. S Tsuji M Tsujii H Murata T Nishida M Komori M Yasumaru, et al. 2006 Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms World J Gastroenterol 12 1671 1680 1:CAS:528: DC%2BD28XkvVaks7o%3D 16586533
5. J Danesh 1999 Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies Aliment Pharmacol Ther 13 851 856 10.1046/j.1365-2036.1999.00546.x 1:STN:280:DyaK1MzhsFansw%3D%3D 10383517 (Pubitemid 29312768)
6. GD Eslick LL Lim JE Byles HH Xia NJ Talley 1999 Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis Am J Gastroenterol 94 2373 2379 10.1111/j.1572-0241.1999.01360.x 1:STN:280: DyaK1MvhtFOqtw%3D%3D 10483994 (Pubitemid 29420659)
7. K Fukase M Kato S Kikuchi K Inoue N Uemura S Okamoto, et al. 2008 Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial Lancet 372 392 397 10.1016/S0140-6736(08)61159-9 18675689
8. BC Wong SK Lam WM Wong JS Chen TT Zheng RE Feng, et al. 2004 Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial JAMA 291 187 194 10.1001/jama.291.2.187 1:CAS:528:DC%2BD2cXkvVCjuw%3D%3D 14722144 (Pubitemid 38082812)
9. S Tsuji M Tsujii S Kawano M Hori 2001 Cyclooxygenase-2 upregulation as a perigenetic change in carcinogenesis J Exp Clin Cancer Res 20 117 129 1:CAS:528:DC%2BD3MXkt1Gju7o%3D 11370818
10. H Yokozaki H Kuniyasu Y Kitadai K Nishimura H Todo A Ayhan, et al. 1992 p53 point mutations in primary human gastric carcinomas J Cancer Res Clin Oncol 119 67 70 10.1007/BF01209657 1:CAS:528:DyaK2cXisVWntL8%3D 1429828
11. QL Li K Ito C Sakakura H Fukamachi K Inoue XZ Chi, et al. 2002 Causal relationship between the loss of RUNX3 expression and gastric cancer Cell 109 113 124 10.1016/S0092-8674(02)00690-6 1:CAS:528:DC%2BD38XjtVOntLs%3D 11955451 (Pubitemid 34327521)
12. Y Oshimo N Oue Y Mitani H Nakayama Y Kitadai K Yoshida, et al. 2004 Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma Pathobiology 71 137 143 10.1159/000076468 1:CAS:528: DC%2BD2cXivVKhsrw%3D 15051926 (Pubitemid 38437708)
13. H Fukamachi K Ito Y Ito 2004 Runx3-/- gastric epithelial cells differentiate into intestinal type cells Biochem Biophys Res Commun 321 58 64 10.1016/j.bbrc.2004.06.099 1:CAS:528:DC%2BD2cXlvVWis78%3D 15358215
14. D Levanon O Brenner F Otto Y Groner 2003 Runx3 knockouts and stomach cancer EMBO Rep 4 560 564 10.1038/sj.embor.embor868 1:CAS:528: DC%2BD3sXktFOgt7o%3D 12776174 (Pubitemid 36939945)
15. Z Zhang S Wang M Wang N Tong G Fu Z Zhang 2008 Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis Carcinogenesis 29 1973 1978 10.1093/carcin/bgn183 1:CAS:528:DC%2BD1cXht1SitLrK 18684727
16. K Tajima K Hirose M Inoue T Takezaki N Hamajima T Kuroishi 2000 A model of practical cancer prevention for out-patients visiting a hospital: the hospital-based epidemiologic research program at Aichi Cancer Center (HERPACC) Asian Pac J Cancer Prev 1 35 47 12718687
17. M Katoh 2007 Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer Cancer Biol Ther 6 832 839 1:CAS:528: DC%2BD2sXht1yktrjJ 17568183
18. P Guilford J Hopkins J Harraway M McLeod N McLeod P Harawira, et al. 1998 E-cadherin germline mutations in familial gastric cancer Nature 392 402 405 10.1038/32918 1:CAS:528:DyaK1cXitlShtL0%3D 9537325 (Pubitemid 28168738)
19. JH Kim T Takahashi I Chiba JG Park MJ Birrer JK Roh, et al. 1991 Occurrence of p53 gene abnormalities in gastric carcinoma tumorsand cell lines J Natl Cancer Inst 83 938 943 10.1093/jnci/83.13.938 1:CAS:528:DyaK3MXmslKqs74%3D 1676761
20. G Tamura T Kihana K Nomura M Terada T Sugimura S Hirohashi 1991 Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis Cancer Res 51 3056 3058 1:CAS:528:DyaK3MXkt1emsbg%3D 2032245
21. K Park SJ Kim YJ Bang JG Park NK Kim AB Roberts, et al. 1994 Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGFbeta Proc Natl Acad Sci USA 91 8772 8776 10.1073/pnas.91.19.8772 1:CAS:528:DyaK2cXmtVajtLs%3D 8090721
22. S Fukushige K Matsubara M Yoshida M Sasaki T Suzuki K Semba, et al. 1986 Localizationof a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line Mol Cell Biol 6 955 958 1:CAS:528:DyaL28XhsVejtb8%3D 2430175
23. G Rege-Cambrin P Scaravaglio F Carozzi S Giordano C Ponzetto PM Comoglio, et al. 1992 Karyotypic analysis of gastric carcinoma cell lines carrying an amplified c-met oncogene Cancer Genet Cytogenet 64 170 173 10.1016/0165-4608(92) 90350-H 1:STN:280:DyaK3s7jslaitw%3D%3D 1486568 (Pubitemid 23044958)
24. T Sano T Tsujino K Yoshida H Nakayama K Haruma H Ito, et al. 1991 Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas Cancer Res 51 2926 2931 1:CAS:528:DyaK3MXkt1emsbs%3D 2032230
25. S Uchino H Tsuda M Noguchi J Yokota M Terada T Saito, et al. 1992 Frequent loss of heterozygosity at the DCC locus in gastric cancer Cancer Res 52 3099 3102 1:CAS:528:DyaK38Xkt1CjsLc%3D 1591722
26. H Kuniyasu W Yasui H Yokozaki M Akagi Y Akama K Kitahara, et al. 1994 Frequent loss of heterozygosity of the long arm of chromosome 7 is closely associated with progression of human gastric carcinomas Int J Cancer 59 597 600 10.1002/ijc.2910590504 1:STN:280:DyaK2M%2FkvVyqtw%3D%3D 7960231 (Pubitemid 24358580)
27. SE Crawford V Stellmach JE Murphy-Ullrich SM Ribeiro J Lawler RO Hynes, et al. 1998 Thrombospondin-1 is a major activator of TGFβ1 in vivo Cell 93 1159 1170 10.1016/S0092-8674(00)81460-9 1:CAS:528:DyaK1cXksVSqs7c%3D 9657149 (Pubitemid 28307421)
28. J Hanai LF Chen T Kanno N Ohtani-Fujita WY Kim WH Guo, et al. 1999 Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter J Biol Chem 274 31577 31582 10.1074/jbc.274.44.31577 1:CAS:528:DyaK1MXntFOjsr8%3D 10531362 (Pubitemid 29508522)
29. T Okuda J van Dursen SW Hiebert G Grosweld JR Downing 1996 AML1, the target of multiple chromosomal translocation in human leukemia, is essential for normal fetal liver hematopoiesis Cell 84 321 330 10.1016/S0092-8674(00)80986-1 1:CAS:528:DyaK28Xnt1egug%3D%3D 8565077 (Pubitemid 26042836)
30. AT Look 1997 Oncogenic transcription factors in the human acute leukemias Science 278 1059 1064 10.1126/science.278.5340.1059 1:CAS:528: DyaK2sXnt1Wju74%3D 9353180 (Pubitemid 27517875)
31. B Lee K Thirunavukkarasu L Zhou L Pastore A Baldini J Hecht, et al. 1997 Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia Nat Genet 16 307 310 10.1038/ng0797-307 1:CAS:528:DyaK2sXktFKjsL0%3D 9207800 (Pubitemid 27280218)
32. S Mundlos F Otto C Mundlos JB Mulliken AS Aylsworth S Albright, et al. 1997 Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia Cell 89 773 779 10.1016/S0092-8674(00)80260-3 1:CAS:528: DyaK2sXjs1ejt74%3D 9182765
33. MC Ghozi Y Bernstein V Negreanu D Levanon Y Groner 1996 Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions Proc Natl Acad Sci USA 93 1935 1940 10.1073/pnas.93.5.1935 1:CAS:528: DyaK28XhsFart7Y%3D 8700862 (Pubitemid 26079858)
34. C Bangsow N Rubins G Glusman Y Bernstein V Negreanu D Goldenberg, et al. 2001 The RUNX3 gene-sequence, structure and regulated expression Gene 279 221 232 10.1016/S0378-1119(01)00760-0 1:CAS:528:DC%2BD3MXoslGktrk%3D 11733147 (Pubitemid 33132184)
35. T Waki G Tamura M Sato M Terashima S Nishizuka T Motoyama 2003 Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia Cancer Sci 94 360 364 10.1111/j.1349-7006.2003. tb01447.x 1:CAS:528:DC%2BD3sXkslCns7w%3D 12824905 (Pubitemid 36626369)
36. GH Kang HJ Lee KS Hwang S Lee JH Kim JS Kim 2003 Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation Am J Pathol 163 1551 1556 1:CAS:528:DC%2BD3sXotlegt7Y%3D 14507661
37. Y Ito 1999 Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF Genes Cells 4 685 696 10.1046/j.1365-2443.1999.00298.x 1:CAS:528:DC%2BD3cXhtVWqsL4%3D 10620014
38. Y Ito 2004 Oncogenic potential of the RUNX gene family: 'overview' Oncogene 23 4198 4208 10.1038/sj.onc.1207755 1:CAS:528:DC%2BD2cXkvVChtrs%3D 15156173 (Pubitemid 38765135)
39. AH Lund M van Lohuizen 2002 RUNX: a trilogy of cancer genes Cancer Cell 1 213 215 10.1016/S1535-6108(02)00049-1 1:CAS:528:DC%2BD38XjsFGltr0%3D 12086855 (Pubitemid 41039143)
40. K Miki M Ichinose A Shimizu SC Huang H Oka C Furihata, et al. 1987 Serum pepsinogens as a screening test of extensive chronic gastritis Gastroenterol Jpn 22 133 141 1:STN:280:DyaL2s3ksl2isw%3D%3D 3596151
41. I Biemond J Kreuning JB Jansen CB Lamers 1994 Serum pepsinogens in patients with gastric diseases or after gastric surgery Scand J Gastroenterol 29 238 242 10.3109/00365529409090470 1:STN:280:DyaK2c3mvFGmtg%3D%3D 8209183
42. A Oksanen P Sipponen A Miettinen S Sarna H Rautelin 2000 Evaluation of blood tests to predict normal gastric mucosa Scand J Gastroenterol 35 791 795 10.1080/003655200750023138 1:STN:280:DC%2BD3cvksVagtQ%3D%3D 10994615
43. H Suzuki T Hibi BJ Marshall 2007 Helicobacter pylori: present status and future prospects in Japan J Gastroenterol 42 1 15 10.1007/s00535-006-1990-z 17322988
44. S Sasazuki M Inoue M Iwasaki T Otani S Yamamoto S Ikeda, et al. 2006 Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study Cancer Epidemiol Biomarkers Prev 15 1341 1347 10.1158/1055-9965.EPI-05-0901 1:CAS:528:DC%2BD28XmslSgtLw%3D 16835334 (Pubitemid 44125292)